The fate of murine double minute X (MdmX) is dictated by distinct signaling pathways through murine double minute 2 (Mdm2)

dc.contributor.authorHauck, Paula M.
dc.contributor.authorWolf, Eric R.
dc.contributor.authorOlivos, David J.
dc.contributor.authorMcAtarsney, Ciaran P.
dc.contributor.authorMayo, Lindsey D.
dc.contributor.departmentPediatrics, School of Medicineen_US
dc.date.accessioned2018-08-03T19:26:01Z
dc.date.available2018-08-03T19:26:01Z
dc.date.issued2017-11-06
dc.description.abstractMouse double minute 2 (Mdm2) and MdmX dimerize in response to low levels of genotoxic stress to function in a ubiquitinating complex, which signals for destabilization of p53. Under growth conditions, Mdm2 functions as a neddylating ligase, but the importance and extent of MdmX involvement in this process are largely unknown. Here we show that when Mdm2 functions as a neddylating enzyme, MdmX is stabilized. Furthermore, we demonstrate that under growth conditions, MdmX enhances the neddylation activity of Mdm2 on p53 and is a substrate for neddylation itself. Importantly, MdmX knockdown in MCF-7 breast cancer cells resulted in diminished neddylated p53, suggesting that MdmX is important for Mdm2-mediated neddylation. Supporting this finding, the lack of MdmX in transient assays or in p53/MdmX-/- MEFs results in decreased or altered neddylation of p53 respectively; therefore, MdmX is a critical component of the Mdm2-mediated neddylating complex. c-Src is the upstream activator of this Mdm2-MdmX neddylating pathway and loss of Src signaling leads to the destabilization of MdmX that is dependent on the RING (Really Interesting New Gene) domain of MdmX. Treatment with a small molecule inhibitor of neddylation, MLN4924, results in the activation of Ataxia Telangiectasia Mutated (ATM). ATM phosphorylates Mdm2, converting Mdm2 to a ubiquitinating enzyme which leads to the destabilization of MdmX. These data show how distinct signaling pathways engage neddylating or ubiquitinating activities and impact the Mdm2-MdmX axis.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationHauck, P. M., Wolf, E. R., Olivos, D. J., McAtarsney, C. P., & Mayo, L. D. (2017). The fate of murine double minute X (MdmX) is dictated by distinct signaling pathways through murine double minute 2 (Mdm2). Oncotarget, 8(61), 104455–104466. https://doi.org/10.18632/oncotarget.22320en_US
dc.identifier.issn1949-2553en_US
dc.identifier.urihttps://hdl.handle.net/1805/16984
dc.language.isoen_USen_US
dc.publisherImpact Journalsen_US
dc.relation.isversionof10.18632/oncotarget.22320en_US
dc.relation.journalOncotargeten_US
dc.rightsAttribution 3.0 United States
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/
dc.sourcePMCen_US
dc.subjectATMen_US
dc.subjectMLN4924en_US
dc.subjectMdm2en_US
dc.subjectMdmXen_US
dc.subjectneddylationen_US
dc.titleThe fate of murine double minute X (MdmX) is dictated by distinct signaling pathways through murine double minute 2 (Mdm2)en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
oncotarget-08-104455.pdf
Size:
3.71 MB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: